1990年至1998年威尔士产志贺毒素大肠杆菌O157的监测
The surveillance of vero cytotoxin-producing Escherichia coli O157 in Wales, 1990 to 1998.
作者信息
Chalmers R M, Parry S M, Salmon R L, Smith R M, Willshaw G A, Cheasty T
机构信息
Public Health Laboratory Service Communicable Disease Surveillance Centre, Cardiff, United Kingdom.
出版信息
Emerg Infect Dis. 1999 Jul-Aug;5(4):566-9. doi: 10.3201/eid0504.990422.
Abstract
Population-based surveillance for Vero cytotoxin-producing Escherichia coli (VTEC) O157 has been carried out in Wales since 1990. The annual incidence has remained stable during the 9-year period (mean: 1.6 cases per 100,000 population); the rate is highest in children younger than 5 years of age. Blood in the stool is reported in fewer than half the cases, indicating the importance of screening all fecal specimens for VTEC O157.
摘要
自1990年以来，威尔士一直在开展基于人群的产志贺毒素大肠杆菌（VTEC）O157监测。在这9年期间，年发病率保持稳定（平均每10万人口中有1.6例）；5岁以下儿童的发病率最高。报告显示，不到一半的病例粪便中有血，这表明对所有粪便标本进行VTEC O157筛查的重要性。
相似文献
1
The surveillance of vero cytotoxin-producing Escherichia coli O157 in Wales, 1990 to 1998.1990年至1998年威尔士产志贺毒素大肠杆菌O157的监测
Emerg Infect Dis. 1999 Jul-Aug;5(4):566-9. doi: 10.3201/eid0504.990422.
2
General outbreaks of vero cytotoxin producing Escherichia coli O157 in England and Wales from 1992 to 1994.1992年至1994年英格兰和威尔士产志贺毒素大肠杆菌O157的总体暴发情况
Commun Dis Rep CDR Rev. 1996 Feb 2;6(2):R26-33.
3
Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.1997 - 2000年德国和奥地利儿童溶血尿毒综合征中产生志贺毒素大肠杆菌感染的临床病程及作用：一项前瞻性研究
J Infect Dis. 2002 Aug 15;186(4):493-500. doi: 10.1086/341940. Epub 2002 Aug 2.
4
Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4.产志贺毒素大肠杆菌，尤其是O157血清型，与英格兰和威尔士1992 - 1994年的人类感染相关
Epidemiol Infect. 1996 Aug;117(1):1-10. doi: 10.1017/s0950268800001060.
5
Vero cytotoxin-producing Escherichia coli O157 infections in Austria.奥地利产志贺毒素大肠杆菌O157感染情况
Z Gastroenterol. 1993 Jun;31(6):388-91.
6
Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.溶血性尿毒症综合征监测，以监测大肠杆菌O157:H7及其他产志贺毒素大肠杆菌感染的趋势。
Emerg Infect Dis. 1997 Jul-Sep;3(3):409-12. doi: 10.3201/eid0303.970329.
7
Vero cytotoxin-producing Escherichia coli O157 outbreaks in England and Wales, 1995: phenotypic methods and genotypic subtyping.1995年英格兰和威尔士产志贺毒素大肠杆菌O157暴发：表型方法与基因分型
Emerg Infect Dis. 1997 Oct-Dec;3(4):561-5. doi: 10.3201/eid0304.970422.
8
Contact with farming environment as a major risk factor for Shiga toxin (Vero cytotoxin)-producing Escherichia coli O157 infection in humans.接触农业环境是人类感染产志贺毒素（维罗细胞毒素）的大肠杆菌O157的主要风险因素。
Emerg Infect Dis. 2001 Nov-Dec;7(6):1049-51. doi: 10.3201/eid0706.010626.
9
Enhanced laboratory-based surveillance of Shiga-toxin-producing Escherichia coli O157 in The Netherlands.荷兰加强对产志贺毒素大肠杆菌O157的实验室监测。
Eur J Clin Microbiol Infect Dis. 2002 Jul;21(7):513-22. doi: 10.1007/s10096-002-0756-7. Epub 2002 Jun 28.
10
Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000.1988 - 2000年意大利与溶血尿毒综合征相关的产志贺毒素大肠杆菌感染
Emerg Infect Dis. 2003 Jan;9(1):106-8. doi: 10.3201/eid0901.020266.
引用本文的文献
1
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.志贺毒素相关性溶血尿毒综合征：成人患者的特点及对重症监护管理的影响。
Toxins (Basel). 2021 Apr 26;13(5):306. doi: 10.3390/toxins13050306.
2
Estimating the burden of foodborne diseases in Japan.估算日本食源性疾病的负担。
Bull World Health Organ. 2015 Aug 1;93(8):540-549C. doi: 10.2471/BLT.14.148056. Epub 2015 Jun 1.
3
E. coli O157 outbreaks in the United Kingdom: past, present, and future.英国大肠杆菌 O157 疫情：过去、现在和未来。
Infect Drug Resist. 2014 Aug 19;7:211-22. doi: 10.2147/IDR.S49081. eCollection 2014.
4
Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.抗体疗法在志贺毒素诱导的溶血性尿毒症综合征治疗中的应用
Clin Microbiol Rev. 2004 Oct;17(4):926-41, table of contents. doi: 10.1128/CMR.17.4.926-941.2004.
5
An epidemiological study on Verotoxin-producing Escherichia coli (VTEC) infection among population of northern region of Iran (Mazandaran and Golestan provinces).伊朗北部地区（马赞德兰省和戈勒斯坦省）人群中产志贺毒素大肠杆菌（VTEC）感染的流行病学研究。
Eur J Epidemiol. 2003;18(4):345-9. doi: 10.1023/a:1023602416726.
6
Primary care surveillance for acute bloody diarrhea, Wales.威尔士急性血性腹泻的初级医疗保健监测
Emerg Infect Dis. 2000 Jul-Aug;6(4):412-4. doi: 10.3201/eid0604.000418.
本文引用的文献
1
Outbreak of Escherichia coli O157 in a nursery: lessons for prevention.托儿所中大肠杆菌O157的暴发：预防经验教训
Arch Dis Child. 1999 Jul;81(1):60-3. doi: 10.1136/adc.81.1.60.
2
Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive.英国感染性肠道疾病研究：社区发病率、全科医疗就诊情况及国家监测报告。感染性肠道疾病研究执行组。
BMJ. 1999 Apr 17;318(7190):1046-50. doi: 10.1136/bmj.318.7190.1046.
3
Problems in the diagnosis of foodborne infection in general practice.全科医疗中食源性感染的诊断问题。
Epidemiol Infect. 1996 Dec;117(3):479-84. doi: 10.1017/s0950268800059148.
4
Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4.产志贺毒素大肠杆菌，尤其是O157血清型，与英格兰和威尔士1992 - 1994年的人类感染相关
Epidemiol Infect. 1996 Aug;117(1):1-10. doi: 10.1017/s0950268800001060.
5
Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91.产志贺毒素大肠杆菌，尤其是血清型O157，与英国1989 - 1991年人类感染有关。
Epidemiol Infect. 1993 Jun;110(3):591-600. doi: 10.1017/s0950268800051013.
6
Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection.大肠杆菌O157:H7：人类感染的临床、诊断及流行病学方面
Clin Infect Dis. 1995 Jan;20(1):1-8; quiz 9-10. doi: 10.1093/clinids/20.1.1.
7
Hemorrhagic colitis associated with a rare Escherichia coli serotype.与一种罕见大肠杆菌血清型相关的出血性结肠炎。
N Engl J Med. 1983 Mar 24;308(12):681-5. doi: 10.1056/NEJM198303243081203.
Zotero 插件